LifeStance Health Gr Financials - Benzinga

LifeStance Health Group Inc

LFSTNASDAQ

Trade with Public

Trade with Public

$12.13

0.050.41%

Dern. MÀJ: Sep 24, 9:30 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

LifeStance Health Gr Financials

LifeStance Health Gr (LFST) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
LifeStance Health Gr Sees Q3 Sales $420.000M-$440.000M vs $418.474M Est

LifeStance Health Gr (NASDAQ:LFST) sees Q3 sales of $420.000 million-$440.000 million vs $418.474 million analyst estimate.

Benzinga Newsdesk

PRO
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est

LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.

Benzinga Newsdesk

PRO
LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M Estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 700 percent increase over losses of $(0.01) per share from

Benzinga Newsdesk

PRO
LifeStance Health Gr Sees Q2 Sales $405.000M-$425.000M vs $401.519M Est

LifeStance Health Gr (NASDAQ:LFST) sees Q2 sales of $405.000 million-$425.000 million vs $401.519 million analyst estimate.

Benzinga Newsdesk

PRO
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.615B-$1.655B to $1.640B-$1.680B vs $1.636B Est

LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.615 billion-$1.655 billion to $1.640 billion-$1.680 billion vs $1.636 billion estimate.

Benzinga Newsdesk

PRO
LifeStance Health Gr Q1 EPS $0.04 Beats $0.01 Estimate, Sales $403.476M Beat $387.367M Estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. The company reported quarterly sales of $403.476 million which beat

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved